Apjohn Group, LLC, is an accomplished team of experienced business and pharmaceutical professionals that has demonstrated success in working with innovators to accelerate the advancement of early-stage life science companies. Our focus is on emerging life science opportunities, which complement our unique strengths in biopharmaceuticals, devices, diagnostics and medical technologies.

Our objective is to accelerate and enhance value for our portfolio companies by bridging the management and financial gap between innovators and the marketplace. Apjohn Group is connected with local and national angel investors and venture capital firms interested specifically in life sciences. Members of the Apjohn Group also have numerous professional connections throughout the very diverse life sciences industry. The Apjohn Group has been an advisor to Apjohn Ventures Fund; the two general partners of the Fund also helped establish the Apjohn Group LLC.

Apjohn Group team members have broad and deep expertise, as well as extensive networks, in all phases of the drug development process from discovery through commercialization.